Rosa Miquel Selected Research

Disease Progression

10/2007	Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis.
3/2006	Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosa Miquel Research Topics

Disease

18	Fibrosis (Cirrhosis) 01/2022 - 09/2003
13	Inflammation (Inflammations) 01/2021 - 09/2003
10	Neoplasms (Cancer) 02/2020 - 04/2002
10	Hepatitis C 06/2016 - 03/2006
7	Infections 01/2018 - 02/2002
6	Liver Cirrhosis (Hepatic Cirrhosis) 05/2016 - 09/2003
6	Chronic Hepatitis C 06/2014 - 02/2004
5	Liver Diseases (Liver Disease) 10/2021 - 09/2003
5	Alcoholic Hepatitis 01/2021 - 02/2007
4	Acute Liver Failure (Fulminant Hepatic Failure) 12/2020 - 04/2010
4	Insulin Resistance 09/2019 - 03/2010
4	Adenocarcinoma 01/2017 - 07/2008
4	Portal Hypertension 08/2014 - 04/2009
3	Autoimmune Hepatitis 06/2020 - 01/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 12/2006
3	Rectal Neoplasms (Rectal Cancer) 11/2014 - 06/2009
2	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 03/2016
2	Cholestasis 10/2021 - 01/2020
2	Acute-On-Chronic Liver Failure 01/2021 - 02/2007
2	Drug Hypersensitivity Syndrome 12/2020 - 04/2010
2	Neoplasm Metastasis (Metastasis) 02/2020 - 12/2017
2	Ascites 11/2018 - 10/2005
2	Hypersensitivity (Allergy) 01/2018 - 04/2010
2	Idiopathic Noncirrhotic Portal Hypertension 06/2013 - 07/2009
2	Hyperlipidemias (Hyperlipidemia) 12/2010 - 03/2010
2	Hepatitis 04/2010 - 02/2005
2	Disease Progression 10/2007 - 03/2006
1	Proteinuria 01/2022
1	Fatty Liver 01/2022
1	AIDS-Related Complex (ARC) 01/2021
1	Chemical and Drug Induced Liver Injury 12/2020
1	Colorectal Neoplasms (Colorectal Cancer) 02/2020
1	Starvation 02/2020
1	Cachexia 01/2020
1	Pruritus (Itching) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Abdominal Obesity 09/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	progressive familial intrahepatic 1 Cholestasis 01/2019
1	Hyperbilirubinemia 01/2019
1	End Stage Liver Disease 01/2019
1	Cystitis 01/2019
1	Intrahepatic Cholestasis 01/2019
1	Jaundice (Icterus) 11/2018

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2020 - 02/2004
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 10/2007
3	Proteins (Proteins, Gene)FDA Link 05/2016 - 06/2004
3	ParaffinIBA 04/2015 - 03/2009
3	Formaldehyde (Formol)FDA Link 04/2015 - 03/2009
3	LipidsIBA 11/2013 - 10/2005
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 03/2010 - 09/2003
2	Fluorouracil (Carac)FDA LinkGeneric 02/2020 - 11/2014
2	Irinotecan (Camptosar)FDA LinkGeneric 02/2020 - 06/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2019
2	Antiviral Agents (Antivirals)IBA 06/2016 - 06/2013
2	Protein Kinases (Protein Kinase)IBA 03/2013 - 12/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010 - 03/2010
2	Apolipoproteins E (ApoE)IBA 12/2010 - 03/2010
2	ApolipoproteinsIBA 12/2010 - 03/2010
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2010 - 03/2010
2	InterleukinsIBA 12/2010 - 03/2010
2	Alanine Transaminase (SGPT)IBA 12/2010 - 03/2010
2	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2007 - 07/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2007 - 07/2005
2	4- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamideIBA 12/2007 - 07/2005
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2003 - 04/2002
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2003 - 04/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2002 - 04/2002
1	Complement C3 (C3 Complement)IBA 01/2022
1	Ointments (Pastes)IBA 10/2021
1	CEACAM1 ProteinIBA 01/2021
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2021
1	CytokinesIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	lysophosphatidic acidIBA 01/2021
1	LigandsIBA 01/2021
1	Rilpivirine (TMC-278)IBA 12/2020
1	Trimethoprim (Proloprim)FDA LinkGeneric 12/2020
1	Immunoglobulin G (IgG)IBA 06/2020
1	Biological ProductsIBA 02/2020
1	Oxygen (Dioxygen)IBA 02/2020
1	Floxacillin (Flucloxacillin)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 09/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2019
1	Cantharidin (Cantharides)IBA 01/2019
1	Nonsense Codon (Nonsense Mutation)IBA 01/2019
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2019
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2019
1	Cefprozil (Cefzil)FDA LinkGeneric 01/2019

Therapy/Procedure

18	Liver Transplantation 01/2022 - 02/2002
15	Therapeutics 01/2020 - 02/2004
3	Transplantation 01/2018 - 03/2006
3	Drug Therapy (Chemotherapy) 12/2017 - 01/2006
3	Radiotherapy 11/2014 - 12/2006
2	Transjugular Intrahepatic Portasystemic Shunt 01/2021 - 10/2005
2	Chemoradiotherapy 11/2014 - 06/2011
1	Bariatric Surgery 04/2020
1	Conservative Treatment 01/2020